Jung, H., Chen, J., Hu, X., Sun, H., Wu, S., Chiang, C., . . . Kemper, J. K. (2020). BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination. JCI Insight.
Chicago Style CitationJung, Hyunkyung, Jinjing Chen, Xiangming Hu, Hao Sun, Shwu-Yuan Wu, Cheng-Ming Chiang, Byron Kemper, Lin-Feng Chen, and Jongsook Kim Kemper. "BRD4 Inhibition and FXR Activation, Individually Beneficial in Cholestasis, Are Antagonistic in Combination." JCI Insight 2020.
MLA CitationJung, Hyunkyung, et al. "BRD4 Inhibition and FXR Activation, Individually Beneficial in Cholestasis, Are Antagonistic in Combination." JCI Insight 2020.
Warning: These citations may not always be 100% accurate.